Answers are grounded in this paper and cite their sources.
Antipeptide antibodies directed to two amino acid sequences predicted from the cDNA encoding the insulin proreceptor have been used to study the relationship between the human receptors for insulin and insulin-like growth factor I (IGF-I).An antibody directed to a cytoplasmic domain near the membrane spanning region of the proreceptor inhibited the protein tyrosine kinase activity of both receptors whereas an antibody directed to the C terminus of the insulin receptor showed no cross-reactivity with the IGF-I receptor.The results establish 1) that the cloned cDNA from the human placenta encodes the insulin receptor and not the closely related IGF-I receptor, 2) that the IGF-I and insulin receptors share a specific amino acid sequence necessary for the expression of enzymatic activity, and 3) that the C terminus of the insulin receptor is not conserved in the IGF-I receptor.The cDNA encoding the precursor of the human placental insulin receptor has recently been cloned by two groups (1, 2).In both studies, the clone was identified by hybridization to oligonucleotide probes based upon N-terminal amino acid sequences of the purified subunits of the processed receptor.Although the features predicted by the cDNA are consistent with the known biochemical properties of the insulin receptor, the cloning strategy employed cannot exclude the possibility that the cDNA might encode a related protein such as the receptor for insulin-like growth factor I. The biological activities of both insulin and insulin-like growth factor I (IGF-I1 or somatomedin C) are initiated by their specific interaction with cell membrane receptors (3-7).Each polypeptide binds
No takes yet. Share an insight, caveat, or question.
Herrera et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: